India and Brazil aim at USD 30 billion with MERCOSUR terms unfinalised
The 8th Trade Monitoring Mechanism recorded bilateral trade of USD 15.07 billion in 2025-26 and a 2030 target of USD 30 billion, while the India-MERCOSUR terms of reference remain to be closed.
What happened
- The 8th India-Brazil Trade Monitoring Mechanism met in Brasília, co-chaired by Commerce Secretary Rajesh Agrawal and Foreign Trade Secretary Tatiana Lacerda Prazeres.
- Bilateral trade reached USD 15.07 billion in 2025-26, against a shared target of USD 30 billion by 2030 in pharmaceuticals, chemicals, engineering goods and machinery.
- With India-MERCOSUR trade at USD 20.84 billion in 2025, both sides committed to early finalisation of the Terms of Reference for expanding the Preferential Trade Agreement.
- The CDSCO-ANVISA MoU of February 2026 was cited as the institutional foundation for pharmaceutical cooperation and more predictable regulatory pathways.
- Progress was noted on mutual recognition of Electronic Certificates of Origin, on phytosanitary requests, and on the BRICS Startup Knowledge Hub and Business Incubator.
For Prelims
- TMM: the India-Brazil Trade Monitoring Mechanism, whose 8th meeting was held in Brasília.
- Bilateral trade: USD 15.07 billion in 2025-26, with a target of USD 30 billion by 2030.
- MERCOSUR: the South American customs union with which India has a Preferential Trade Agreement; India-MERCOSUR trade was USD 20.84 billion in 2025.
- Terms of Reference: the document setting the scope for expanding and modernising the PTA — still to be finalised, not the agreement itself.
- ANVISA: Brazil's health regulator, counterpart to India's CDSCO; their MoU was signed in February 2026.
- Phytosanitary measures: plant health requirements that condition agricultural market access; priority requests were advanced on both sides.
- Electronic Certificates of Origin: digital proof of a good's origin for preferential tariff purposes, moving towards mutual recognition.
- ApexBrasil: Brazil's trade and investment promotion agency, which has opened an office in New Delhi.
For UPSC: A compact case of trade diplomacy where the obstacles are regulatory rather than tariff, and of a bilateral track running alongside a bloc negotiation. Use it on India's engagement with Latin America, on preferential trade agreements, and on non-tariff barriers.
What it is NOT: Nothing was signed here — this is a review meeting, and even on MERCOSUR what is being finalised is the terms of reference for negotiations, not the expanded agreement.
For Mains
Syllabus: GS2.18 · GS3.1 · Linkage L2
Anchor
India trades more with MERCOSUR as a bloc, USD 20.84 billion, than with Brazil alone at USD 15.07 billion — and after eight meetings the two sides are still finalising the terms of reference for talks, not the talks themselves.
Substantiation (data)
Bilateral trade USD 15.07 billion in 2025-26 against a USD 30 billion target for 2030; India-MERCOSUR trade USD 20.84 billion in 2025; the CDSCO-ANVISA MoU of February 2026; over 25 Indian firms at the Brasília business reception.
Exemplification
The pharmaceutical ask is directed at a regulator, not a tariff line: what India seeks from Brazil is a predictable ANVISA registration pathway, which is why the instrument is a regulator-to-regulator memorandum.
Problematisation
A doubling of trade by 2030 is asserted without a sectoral pathway, and the substantive items — phytosanitary clearances, certificates of origin, regulatory recognition — are the slow kind that no target can accelerate.
Way-forward
Closing the MERCOSUR terms of reference is the single step that would convert eight rounds of monitoring into a negotiation with a deadline.
Position
India's trade barriers in Latin America are administrative rather than fiscal, so the useful diplomacy is between regulators and standards bodies, not between trade ministries setting targets.
Deploys into: Groupings and agreements + Indian economy (GS2.18, GS3.1) · India-Brazil and India-MERCOSUR trade, and non-tariff barriers as the operative constraint.
Ministry of Commerce & Industry · 2026-08-31 · PRID 2304804 · PIB source ↗